Sophie Pierce is determined to make the most of her life - however long she may have.

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.

Brensocatib targets the underlying cause of inflammation in NCFBE (Non-Cystic Fibrosis Bronchiectasis) by inhibiting neutrophil serine proteases (NSPs). Current treatments only manage symptoms, and ...

Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Each child had already undergone at least three open-heart surgeries. They'd endured countless hours in doctors' offices and ...

The Ministry of Health and Prevention’s focus on premarital genetic testing represents a revolutionary shift in how health is ...